SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coronavirus / COVID-19 Pandemic
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Moonray10/28/2021 1:24:54 PM
3 Recommendations

Recommended By
B.K.Myers
Glenn Petersen
oldbeachlvr

   of 22868
 
The pill, called fluvoxamine, would cost $4
for a course of COVID-19 treatment. By comparison,
antibody IV treatments cost about $2,000 and
Merck's experimental antiviral pill for COVID-19
is about $700 per course. Some experts predict
various treatments eventually will be used in
combination to fight the coronavirus.

More at: Cheap antidepressant shows
promise treating early COVID-19

o~~~ O
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News